I find out tomorrow whether I'll be entering a phase 2 clinical trial of a PARP inhibitor, niraparib (Zejula). I have a CDK12 DNA repair mutation that makes me a candidate for this intervention. (NCT02854436)
Looking for anyone who has experience with this or other PARP inhibitors re effectiveness and side effects.
TIA